Development and validation of a nomogram to predict postoperative cancer-specific survival of patients with nonmetastatic T3a renal cell carcinoma

CONCLUSION: The current nomogram could effectively predict the CSS of patients with nonmetastatic T3a RCC, and could be used to identify patients who might need a compact interval of follow-up and postoperative adjuvant systemic treatment. The limitations included the retrospective nature, absence of external validation, and several unmeasured variables related to the selection bias of surgery type. The results should be interpreted with caution.PMID:34620554 | DOI:10.1016/j.urolonc.2021.06.014
Source: Urologic Oncology - Category: Urology & Nephrology Authors: Source Type: research